门冬氨酸钾减轻大鼠可控性皮质打击伤引起的脑损伤

doi:10.3969/j.issn.1673-5765.2017.06.005

摘要/Abstract

摘要：

目的门冬氨酸钾（potassium aspartate，PA）作为一种电解质补充剂，在临床上广泛使用。以往的研究发现门冬氨酸钾在脑缺血/再灌注大鼠中对细胞凋亡有神经保护的作用。本研究将探讨门冬氨酸钾对创伤性脑损伤（traumatic brain injury，TBI）是否有保护作用。方法 T BI通过大鼠可控性皮质打击伤（controlled c ortical i mpact，CCI）产生。门冬氨酸钾组或溶剂对照组在CCI发生后30 min以腹腔注射给予生理盐水或62.5 mg/kg剂量的PA，观察脑血流灌注量，改良神经功能缺损评分（modified Neurological Severity Score，mNSS）和皮质损伤体积，并检测脑水肿以及脑组织三磷腺苷（adenosine triphosphate，ATP）、乳酸含量和钠钾ATP酶活性。结果在CCI引起的大鼠皮质损伤中，与溶剂对照组相比，急性给予62.5 mg/kg剂量的PA治疗可以明显改善神经功能缺损（P＜0.05)，降低皮质损伤体积（P＜0.01），减轻脑水肿（P＜0.05）。此外，与溶剂对照组相比，门冬氨酸钾治疗组显著减少ATP缺失（P＜0.01），降低乳酸含量（P＜0.05），并增加钠钾ATP酶的活性（P＜0.05）。结论 PA能通过增加ATP含量和钠钾ATP酶的活性并降低脑水肿，对TBI具有神经保护作用。这为PA 在临床脑损伤时的应用提供了实验证据。

文章导读： 门冬氨酸钾能通过提高三磷腺苷水平，增加钠钾三磷腺苷酶活性和降低脑水肿，对创伤性脑损伤有神经保护作用，本研究可为门冬氨酸钾的临床应用提供实验证据。

关键词: 门冬氨酸钾; 脑损伤; 可控性皮质打击伤; 钠钾ATP酶

Abstract:

Objective Potassium aspartate (PA), as an electrolyte supplement, is widely used in clinical practice. Previous study found PA had neuroprotective effects against apoptosis after cerebral ischemia/reperfusion in rats. This study is to investigate whether PA has protective effects on traumatic brain injury. Methods Traumatic brain injury (TBI) was induced by controlled cortical impact (CCI) in rats. Vehicle treatment group or potassium aspartate treatment group were administered saline via intraperitoneal injection or PA at the dose of 62.5 mg/kg at 30 minutes after onset of CCI. The brain blood perfusion, modified Neurological Severity Score (mNSS), and cortical lesion volume were observed. Brain edema brain ATP contents, lactic acid concentration, and Na+/K+-ATPase activities were measured. Results In controlled cortical impact induced cortical injury in rats, compared with vehicle-only treatment, PA treatment during the acute phase of MCAO at the dose of 62.5 mg/kg significantly improved neurological deficits (P <0.05), decreased the cortical lesion volume (P <0.01), and alleviated brain edema (P <0.05). In addition, PA treatment significantly reduced the loss of ATP (P <0.01), reduced lactic acid levels (P <0.05), and increased the activity of Na+/K+-ATPase (P <0.05). Conclusion PA had neuroprotective effects on TBI through increasing ATP, Na+/K+-ATPase activity, and reducing brain edema. It provides experimental evidence for the clinical application of PA in clinical treatment of brain injury.

Key words: Aspartic acid; Brain injury; Controlled cortical impact; Ischemia; Na+/K+-ATPase

顾漪，赵育梅，苏玉金. 门冬氨酸钾减轻大鼠可控性皮质打击伤引起的脑损伤[J]. 中国卒中杂志, 2017, 12(06): 489-495.

GU Yi,ZHAO Yu-Mei, SU Yu-Jin. Potassium Aspartate Alleviates Brain Injury Induced by Controlled Cortical Impact in Rats[J]. Chinese Journal of Stroke, 2017, 12(06): 489-495.

参考文献

1 Hirst TC，Watzlawick R，Rhodes JK，et al. Study

protocol - A systematic review and meta-analysis

of hypothermia in experimental traumatic brain

injury：Why have promising animal studies not been

replicated in pragmatic clinical trials?[J]. Evid Based

Preclin Med，2016，3：e00020.

2 Cheng G，Kong RH，Zhang LM，et al. Mitochondria

in traumatic brain injury and mitochondrialtargeted

multipotential therapeutic strategies[J]. Br J

Pharmacol，2012，167：699-719.

3 Shultz SR，McDonald SJ，Vonder Haar C，et al. The

potential for animal models to provide insight into

mild traumatic brain injury：Translational challenges

and strategies[J]. Neurosci Biobehav Rev，2016 Sep

19. [Epub ahead of print]

4 Winkler EA，Minter D，Yue JK，et al. Cerebral

edema in traumatic brain injury：pathophysiology and

prospective therapeutic targets[J]. Neurosurg Clin N

Am，2016，27：473-488.

5 石奇龙. 天冬氨酸钾镁的药理作用[J]. 湖南医学，1990，

7：57-58.

6 顾漪，赵育梅，龚磊，等. 门冬氨酸钾对局灶性脑缺血

再灌注大鼠的保护作用研究[J]. 中国卒中杂志，2014，

9：100-105.

7 Bramlett HM，Dietrich WD. Pathophysiology of

cerebral ischemia and brain trauma：similarities and

differences[J]. J Cereb Blood Flow Metab，2004，24：

133-150.

8 Osier ND，Dixon CE. The controlled cortical impact

model：applications，considerations for researchers，

and future directions[J]. Front Neurol，2016，7：134.

9 NC3Rs Reporting Guidelines Working Group. Animal

research：reporting in vivo experiments：the ARRIVE

guidelines[J]. J Physiol，2010，588：2519-2521.

10 Kobeissy FH. Brain Neurotrauma：Molecular，

Neuropsychological，and Rehabilitation Aspects[M].

Boca Raton (FL)：CRC Press/Taylor & Francis，2015，

Chapter 16.

11 Chen J，Sanberg PR，Li Y et al. Intravenous

administration of human umbilical cord blood reduces

behavioral deficits after stroke in rats[J]. Stroke，2001，

32：2682-2688.

12 诸葛启钏. 大鼠脑立体定位图谱[M]. 3版. 北京：人民

卫生出版社，2005：85-190.

13 Sun M，Zhao Y，Gu Y，et al. Protective effects

of taurine against closed head injury in rats[J]. J

Neurotrauma，2015，32：66-74.

14 D’Ambrosio R，Maris DO，Grady MS，et

al. Impaired K(+) homeostasis and altered

electrophysiological properties of post-traumatic

hippocampal glia[J]. J Neurosci，1999，19：8152-8162.

15 Armstead WM，Riley J，Vavilala MS. TBI sex

dependently upregulates ET-1 to impair autoregulation，

which is aggravated by phenylephrine in males but

is abrogated in females[J]. J Neurotrauma，2012，29：

1483-1490.

16 Filippidis AS，Liang X，Wang W，et al. Real-time

monitoring of changes in brain extracellular sodium

and potassium concentrations and intracranial

pressure after selective vasopressin-1a receptor

inhibition following focal traumatic brain injury in

rats[J]. J Neurotrauma，2014，31：1258-1267.

17 Lee YK，Lee CW，Huang MY，et al. Increased risk of

ischemic stroke in patients with mild traumatic brain

injury：a nationwide cohort study[J]. Scand J Trauma

Resusc Emerg Med，2014，22：66.

18 Burke JF，Stulc JL，Skolarus LE，et al. Traumatic

brain injury may be an independent risk factor for

stroke[J]. Neurology，2013，81：33-39.

19 Gu Y，Zhao Y，Qian K，et al. Taurine attenuates

hippocampal and corpus callosum damage，and

enhances neurological recovery after closed head

injury in rats[J]. Neuroscience，2015，291：331-340.

20 Donnelly J，Budohoski KP，Smielewski P，et al.

Regulation of the cerebral circulation：bedside

assessment and clinical implications[J]. Crit Care，

2016，20：129.

21 Laskowitz D，Grant G. Translational Research in

Traumatic Brain Injury[M]. Boca Raton (FL)：CRC

Press/Taylor and Francis Group，2016，Chapter 5.

22 Klatzo I. Neuropathological aspects of brain edema[J].

J Neuropathol Exp Neurol，1967，26：1-14.

23 Milhorat TH. Classification of the cerebral edemas

with reference to hydrocephalus and pseudotumor

cerebri[J]. Childs Nerv Syst，1992，8：301-306.

24 Tang G，Yang GY. Aquaporin-4：a potential

therapeutic target for cerebral edema[J]. Int J Mol Sci，

2016，17. pii：E1413.

25 Li T，Wang N，Zhao M. Neuroprotective effect

of phosphocreatine on focal cerebral ischemiareperfusion

injury[J]. J Biomed Biotechnol，2012，

2012：168 756.

26 Holm TH，Lykke-Hartmann K. Insights into the

pathology of the α3 Na(+)/K(+)-ATPase ion pump in

neurological disorders; lessons from animal models[J].

Front Physiol，2016，7：209.

27 Dvela-Levitt M，Ami HC，Rosen H，et al. Ouabain

improves functional recovery following traumatic

brain injury[J]. J Neurotrauma，2014，31：1942-1947.

28 Silva LF，Hoffmann MS，Rambo LM，et al. The

involvement of Na+/K+-ATPase activity and

free radical generation in the susceptibility to

pentylenetetrazol-induced seizures after experimental

traumatic brain injury[J]. J Neurol Sci，2011，308：35-

40.

29 Gerbatin RD，Cassol G，Dobrachinski F，et al.

Guanosine protects against traumatic brain injuryinduced

functional impairments and neuronal loss by

modulating excitotoxicity，mitochondrial dysfunction，

and inflammation[J]. Mol Neurobiol，2016 Nov 9.

[Epub ahead of print]

30 Barlow KM，Marcil LD，Dewey D，et al. Cerebral

Perfusion Changes in Post-Concussion Syndrome：

A Prospective Controlled Cohort Study[J]. J

Neurotrauma，2017，34：996-1004.

31 Eme R. Neurobehavioral Outcomes of Mild Traumatic

Brain Injury：A Mini Review[J]. Brain Sci，2017，7：46.

[1]	张琳瑶, 刘丽旭. 多巴胺受体激动剂在缺血性脑损伤后脑保护研究进展[J]. 中国卒中杂志, 2024, 19(10): 1215-1220.
[2]	孔德敏, 邹伟. 脑出血后小胶质细胞极化及其相关炎症信号通路对继发性脑损伤的影响[J]. 中国卒中杂志, 2023, 18(11): 1315-1323.
[3]	李波, 胡永珍, 李雪松. 自发性脑出血后继发性脑损伤的影像学研究进展[J]. 中国卒中杂志, 2023, 18(03): 347-352.
[4]	董雯, 姜鸣钰, 陈文涛, 刘文倩, 陈青芳, 赵顺英, 叶维贞, 温少红, 刘向荣. 阿司匹林和氯吡格雷联合应用对小鼠脑缺血损伤后骨髓及脑内炎症反应的影响[J]. 中国卒中杂志, 2022, 17(06): 605-610.
[5]	刘文倩, 赵顺英, 叶维贞, 姜鸣钰, 陈文涛, 陈青芳, 温少红, 董雯, 刘向荣 . 毛柳苷在缺血性脑损伤中对白介素4诱导蛋白1表达和小胶质细胞激活及表型的影响[J]. 中国卒中杂志, 2022, 17(02): 134-141.
[6]	宋璐, 王泳, 李海东, 刘洁, 李征, 张文静, 高亚立, 刘月伟, 陆敏杰. 重度获得性脑损伤患者成功拔除气切套管的相关因素分析[J]. 中国卒中杂志, 2021, 16(07): 699-704.
[7]	廖艺斐，张慧，邹良玉. 神经炎症在动脉瘤性蛛网膜下腔出血后早期脑损伤中的作用[J]. 中国卒中杂志, 2021, 16(01): 92-96.
[8]	朱燕，朱东亚. 脑出血后继发性脑损伤的机制与治疗[J]. 中国卒中杂志, 2019, 14(02): 183-187.
[9]	刘昌亚, 胡学斌, 熊志勇, 郑津, 刘杨, 姚凡. 丁苯酞注射液对动脉瘤性蛛网膜下腔出血早期脑损伤的作用与机制探讨[J]. 中国卒中杂志, 2018, 13(07): 692-695.
[10]	师忠芳，徐立新，闫旭，董丽萍，袁芳. 腺苷酸活化蛋白激酶在星形胶质细胞中的表达[J]. 中国卒中杂志, 2017, 12(07): 604-608.
[11]	陶雯，杨一萍，朱靓，倪海丹，徐添，柯开富. 2015NCS循证指南：神经危重症患者静脉血栓形成的预防[J]. 中国卒中杂志, 2016, 11(10): 886-893.
[12]	梁志锋，洪晔，张晓颖，刘松怀，刘敏，宋鲁平，刘丽旭，赵军. 脑损伤康复患者脑电心理评估与焦虑和抑郁情绪评估相关性分析[J]. 中国卒中杂志, 2016, 11(09): 733-737.
[13]	吴介洪，胡波. 脑出血后继发缺血性脑损伤研究进展[J]. 中国卒中杂志, 2014, 9(12): 989-992.
[14]	李朝霞，赵性泉. 蛛网膜下腔出血早期脑损伤发病机制综述[J]. 中国卒中杂志, 2014, 9(03): 241-.
[15]	顾漪1，赵育梅1，龚磊2，于航3，王拥军4，张亚卓2. 门冬氨酸钾对局灶性脑缺血再灌注大鼠的保护作用研究[J]. 中国卒中杂志, 2014, 9(02): 100-105.